Citrobacter complicated UTI

A complicated urinary tract infection caused by *Citrobacter* species refers to a symptomatic bacterial infection of the upper or lower urinary tract occurring in the setting of structural, functional, or host-related abnormalities Pathophysiologically, opportunistic gram-negative coliforms such as *Citrobacter freundii* or *Citrobacter koseri* colonize and invade the urothelium, frequently manifesting with dysuria, fever, flank pain, or signs of systemic sepsis

A complicated urinary tract infection caused by *Citrobacter* species refers to a symptomatic bacterial infection of the upper or lower urinary tract occurring in the setting of structural, functional, or host-related abnormalities This condition primarily affects hospitalized, catheterized, older adult, or immunocompromised patients, as well as individuals with urinary tract obstruction or neurogenic bladder

This condition primarily affects hospitalized, catheterized, older adult, or immunocompromised patients, as well as individuals with urinary tract obstruction or neurogenic bladder Pathophysiologically, opportunistic gram-negative coliforms such as *Citrobacter freundii* or *Citrobacter koseri* colonize and invade the urothelium, frequently manifesting with dysuria, fever, flank pain, or signs of systemic sepsis Clinical management is often challenging due to intrinsic or acquired resistance mec...

This condition primarily affects hospitalized, catheterized, older adult, or immunocompromised patients, as well as individuals with urinary tract obstruction or neurogenic bladder Pathophysiologically, opportunistic gram-negative coliforms such as *Citrobacter freundii* or *Citrobacter koseri* colonize and invade the urothelium, frequently manifesting with dysuria, fever, flank pain, or signs of systemic sepsis Clinical management is often challenging due to intrinsic or acquired resistance mec...

Pathophysiologically, opportunistic gram-negative coliforms such as *Citrobacter freundii* or *Citrobacter koseri* colonize and invade the urothelium, frequently manifesting with dysuria, fever, flank pain, or signs of systemic sepsis

Clinical management is often challenging due to intrinsic or acquired resistance mechanisms—including inducible AmpC beta-lactamases and biofilm production—which increase the risk of therapeutic failure, ascending pyelonephritis, or recurrent bacteremia